HBR | Jotup

WiMi Developed a 3D Human Behavior Recognition Algorithm System Based on Convolutional Neural Network

Retrieved on:

Wednesday, August 16, 2023

Cloud, Holography, Skeleton, Augmented reality, Classification, HBR, WIMI, 3D, Data collection, Overfitting, CNN, Data, Deep learning, Memory, AR, Behavior, Mobile phone

BEIJING, Aug. 16, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a 3D human behavior recognition algorithm system based on convolutional neural network (CNN), which has the good representational ability, was developed.

Key Points:

BEIJING, Aug. 16, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a 3D human behavior recognition algorithm system based on convolutional neural network (CNN), which has the good representational ability, was developed.
Human Behavior Recognition (HBR) is the process of deciphering human behaviors through sophisticated techniques in order to enable machines to understand, analyze, comprehend, and classify these behaviors and give any kind of valid input or stimulus.
More specifically, the system is using data for a 3D human behavior recognition task by extracting four types of informative features (distance, distance velocity, angle, and angle velocity features) from the 3D skeleton data and encoding them into an image using a suitable encoding scheme.
The requirements of human behavior recognition networks for the dataset include comprehensive behavioral categories, high-quality of behavior, clear video and so on.

Harvard Business Review Research Reveals How AI Is Making the Recruiting Process More Effective -- and Positively Impacting Business Success

Retrieved on:

Tuesday, August 15, 2023

SCOTTSDALE, Ariz., Aug. 15, 2023 /PRNewswire/ -- The Harvard Business Review (HBR) today released research that studied the impact AI is having in talent acquisition effectiveness and overall business success. The study was completed in partnership with Paradox, the conversational recruiting software helping companies like Unilever, Nestlé, Pfizer, and General Motors automate recruiting work to make the hiring process more efficient.

Key Points:

SCOTTSDALE, Ariz., Aug. 15, 2023 /PRNewswire/ -- The Harvard Business Review (HBR) today released research that studied the impact AI is having in talent acquisition effectiveness and overall business success.
The study was completed in partnership with Paradox , the conversational recruiting software helping companies like Unilever, Nestlé, Pfizer, and General Motors automate recruiting work to make the hiring process more efficient.
"By taking a closer look at their priorities, their processes, and their technologies, this focused attention is making a difference in their hiring outcomes.
Just 4% of respondents said that their organization is currently "very effective" at hiring the talent it needs.

Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr

Retrieved on:

Monday, July 31, 2023

GSK, IV, Prevalence, HBR, Pyelonephritis, Cutis verticis gyrata, AP, MDR, Patient, SPA, Infection, Rare, FDA, Therapy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Spero

CAMBRIDGE, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in areas of high unmet need involving rare diseases and multi-drug resistant (MDR) bacterial infections, announced today that it received written agreement from the U.S. Food and Drug Administration (FDA), under a Special Protocol Assessment (SPA), on the design and size of PIVOT-PO, a pivotal Phase 3 clinical trial of tebipenem HBr in patients with complicated urinary tract infection (cUTI), including acute pyelonephritis (AP).

Key Points:

“PIVOT-PO was designed in collaboration with GSK to provide tebipenem HBr with a clinical path to becoming the first oral carbapenem antibiotic for treatment of cUTI, if approved,” said Dr. Kamal Hamed, Chief Medical Officer of Spero.
“With increasing prevalence of antibiotic-resistant bacteria, cUTI patients often have no choice but to receive an intravenous (IV) carbapenem antibiotic in a hospital setting.
The goal of our tebipenem HBr program is to provide appropriate patients with an efficacious oral option for the treatment of cUTI.
We believe that tebipenem HBr has the potential to deliver strong value to the healthcare system.”
PIVOT-PO is a global, randomized, double-blind, pivotal Phase 3 clinical trial of oral tebipenem HBr vs. IV imipenem cilastatin, in hospitalized adult patients with cUTI/AP.

HBR Consulting Expands Portfolio with Strategic Investment in KP Labs by Renovus Capital Partners

Retrieved on:

Tuesday, July 11, 2023

Partnership, HBR, All-star, De Felice, LAC Group, Growth, CIO, LAC, BTI, Automation, Drug

CHICAGO, July 11, 2023 /PRNewswire/ -- HBR Consulting (HBR), a leading provider of strategy, operations, and technology services to the legal industry, is pleased to announce that Renovus Capital Partners (Renovus) has acquired Keesal Propulsion Labs (KP Labs), a renowned company specializing in business and legal process innovation and automation. This investment marks an important milestone in the continued growth of the portfolio of Renovus-backed businesses serving law firms and corporations.

Key Points:

CHICAGO, July 11, 2023 /PRNewswire/ -- HBR Consulting (HBR), a leading provider of strategy, operations, and technology services to the legal industry, is pleased to announce that Renovus Capital Partners (Renovus) has acquired Keesal Propulsion Labs (KP Labs), a renowned company specializing in business and legal process innovation and automation.
As part of Renovus' expanding portfolio, which includes HBR, LAC Group, and Wilson Allen, the addition of KP Labs brings deep expertise and capabilities in advanced analytics, contract intelligence, workflow design, and business process automation solutions.
This strategic alignment empowers HBR and KP Labs to deliver comprehensive end-to-end solutions and drive innovation to meet the evolving needs of clients.
Matt Sunderman, CEO of HBR + LAC + Wilson Allen , remarked, "We are thrilled to welcome KP Labs.

Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer

Retrieved on:

Wednesday, June 14, 2023

CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Satyavrat “Sath” Shukla, Spero’s current Chief Financial Officer and Treasurer, will serve as Spero’s President and Chief Executive Officer (CEO), and as a member of the Board of Directors, effective August 1, 2023.

Key Points:

Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective August 1, 2023
Current President and Chief Executive Officer, Ankit Mahadevia, M.D to become Chairman of the Board of Directors
CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Satyavrat “Sath” Shukla, Spero’s current Chief Financial Officer and Treasurer, will serve as Spero’s President and Chief Executive Officer (CEO), and as a member of the Board of Directors, effective August 1, 2023.
Mr. Shukla will succeed Spero’s current CEO and President, Ankit Mahadevia, M.D., who will become Chairman of the Board of Directors, effective August 1, 2023.
“It has been an honor to lead Spero since its inception and I am thrilled to welcome Sath as our next CEO,” said Ankit Mahadevia, M.D., Chief Executive Officer of Spero Therapeutics.
Until this search is completed, the Board has appointed Stephen J. DiPalma as Interim CFO and Treasurer, effective August 1, 2023.

Harvard Business Review to Host ‘Leaders Who Make a Difference’ Virtual Conference Next Week

Retrieved on:

Tuesday, May 16, 2023

Harvard Business Review will be hosting its third annual virtual HBR Live: Leaders Who Make a Difference conference next Tuesday, May 23, 2023.

Key Points:

Harvard Business Review will be hosting its third annual virtual HBR Live: Leaders Who Make a Difference conference next Tuesday, May 23, 2023.
The daylong program—filled with CEO interviews, expert-led mini-masterclasses, and more—will explore responsible AI, talent management, inclusive capitalism, DEI, and other top-of-mind topics.
Participants will come away equipped with proven strategies to drive positive change in their own organizations.
Speakers and sessions will include:
Revathi Advaithi, CEO, Flex – Managing a Global, Next-Gen Manufacturing Workforce
For the agenda and complete list of confirmed speakers, visit HBR Live: Leaders Who Make a Difference .

HBR Consulting, LAC Group, and Wilson Allen Announce Executive Leadership Team for Combined Organization

Retrieved on:

Thursday, May 11, 2023

Information technology, Marketing, HBR, Integration, Intelligence, Mullock, Thought, Running, LAC Group, LAC, Corporate development, Sales, Management

CHICAGO, May 11, 2023 /PRNewswire/ -- HBR Consulting, LAC Group, and Wilson Allen today announced the executive leadership team for a new, combined organization that unites the strengths of three trusted advisors to law firms and corporations worldwide. HBR, which advises legal industry clients on strategy, operational improvements, and technology, was acquired by Renovus Capital Partners in 2022, as were legal research and competitive intelligence provider LAC Group and legal technology and data consultancy Wilson Allen. Together, the combination creates a market-leading, multidisciplinary powerhouse with decades of experience providing services and solutions to law firms, corporate law departments, and other information-driven enterprises. In the short term, the organization will continue to go to market under the three existing brands; a new brand will be launched later in 2023.

Key Points:

Matt Sunderman, now Chief Executive Officer of the combined organization, said: "Clients told us they want a broader scope of services, and we listened.
Rob Corrao, now Executive Chairman, said: "Our unified organization is fully committed to our clients, each other, and our role in the legal ecosystem.
The new leadership team features executives from all three legacy companies:
Matt Sunderman, Chief Executive Officer.
More information about the combined organization's Executive Leadership Team and the Senior Leadership Team can be found on the HBR , LAC , and Wilson Allen websites.

London Business School Professor Wins 2022 HBR Prize

Retrieved on:

Tuesday, April 11, 2023

Professional Services, Education, Communications, Other Education, Consulting, Publishing, University, Linda, Entrepreneurship, HBR, London Business School, McDonough School of Business, Business, Harvard Business Review, Stanford University School of Engineering, Harvard Business School, Management, Engineering

An article debunking common myths about digital disruption has won the 2022 HBR Prize, which honors the best Harvard Business Review article of the year.

Key Points:

An article debunking common myths about digital disruption has won the 2022 HBR Prize, which honors the best Harvard Business Review article of the year.
In “ How Incumbents Survive and Thrive ,” London Business School professor Julian Birkinshaw challenges the prevailing narrative around technological disruption — namely, that no industry is immune, digital disruption happens quickly, and most established firms are unable to adapt.
“The judges praised the article’s excellent research base, relevance to today’s companies, and insightful framework for leaders.”
Julian Birkinshaw is Professor of Strategy and Entrepreneurship and the Vice Dean of London Business School.
The judging panel recognized two other articles as HBR Prize finalists:
“ The Essential Link Between ESG Targets & Financial Performance ,” by Mark R. Kramer and Marc W. Pfitzer
The 2022 HBR Prize judges were: Kathleen Eisenhardt, professor, Stanford School of Engineering; Claudio Fernández-Aráoz, former partner, Egon Zehnder; Sunil Gupta, professor, Harvard Business School; Linda Hill, professor, Harvard Business School; Hubert Joly, former CEO and chairman, Best Buy; Stefan Thomke, professor, Harvard Business School; and Ella Washington, professor, Georgetown University McDonough School of Business.

Harvard Business Review to Host ‘Future of Business’ Conference on March 6 as Part of 100th Anniversary Celebration

Retrieved on:

Tuesday, February 28, 2023

Professional Services, Communications, Other Professional Services, Finance, Other Communications, Public Relations, Investor Relations, Lincoln Center, IBM, Harvard Business Review, Business, Lincoln, Blue Ocean Strategy, HBR, Global Peter Drucker Forum, INSEAD, Economic Insights, Management

Harvard Business Review has announced the final speaker lineup and agenda for its HBR at 100: Future of Business conference, to be held virtually on March 6, 2023.

Key Points:

Harvard Business Review has announced the final speaker lineup and agenda for its HBR at 100: Future of Business conference, to be held virtually on March 6, 2023.
The daylong event marking HBR’s centennial will convene top CEOs and experts to explore the best ideas in management and what’s next for business.
On March 7, it will be hosting an in-person centennial gala at New York City’s Jazz at Lincoln Center featuring additional business and cultural leaders.
Media who would like to cover HBR at 100: Future of Business should contact Amy Poftak at [email protected] .

Terra Balcanica Intersects 505 g/t AgEq Over 11.0 m Including 3,075 g/t AgEq (108.5 oz/т AgEq) over 1.7 m At Viogor-Zanik in Bosnia

Retrieved on:

Monday, February 27, 2023

PQ3, News, SW, National instrument, Silver, HNO3, ICP-AES, Digestion, Soil, HBR, ISO/IEC, Horizontal drillhole disposal, Potassium chlorate, Composite, Gold, ALS

Vancouver, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce further, high-grade drill results including step-out drillholes at Cumavici Ridge and a new discovery at the Josheva target extending mineralization at the Cumavici Corridor over 2.3 km to the southeast within its flagship, 216 km2 Viogor-Zanik project in Bosnia and Herzegovina.

Key Points:

Further Exploration Drilling: Further drilling will systematically test the high-grade Cumavici vein along strike to the NW/SE and down-dip SW where the mineralization is open and untested.
The Cumavici Ridge target lies within a local magnetic low, which is continuous for > 500 m strike length.
Due to the shallow nature of this high-grade system, drilling can quickly define strike length utilizing a 40 m regular step out.
Dr. Mišković has reviewed and validated the information contained in this news release as factual and accurate.